A study on a gut hormone and bone health
Part of Bones, joints & muscles, Hormones & metabolism clinical trials.
This trial looks at how a natural gut hormone (GIP) affects bone remodeling in healthy people. If you are healthy, you may help us understand how this hormone works on bone cells.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a healthy volunteer
- You cannot have pre-diabetes or diabetes (HbA1c above 42 mmol/mol)
- Your BMI must be 28 or lower
- You must not have had a broken bone in the last 6 months
- You cannot be pregnant
- You must be able to give informed consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a diabetes medication called a GLP-1 receptor agonist can help improve bone and muscle health in older women with type 2 diabetes who are at risk for osteoporosis. It aims to see if the drug can strengthen bones and prevent falls.
This study looks at whether better blood sugar control changes levels of a hormone called irisin in people with type 2 diabetes and obesity, including those with or without age-related muscle loss (sarcopenia). Your results may help researchers understand the body’s response to diabetes and could guide future treatment ideas.
This study uses a special full-body PET scan to see how two natural hormones, GIP and GLP-1, affect how your body uses sugar and moves blood. It includes healthy volunteers and people with type 2 diabetes who are on metformin only.
This study looks at how a natural gut hormone called GIP affects blood pressure after a meal. It may help find new ways to treat blood pressure problems after eating.
This study looks at how eating affects blood flow in your bones. Healthy volunteers between 25 and 50 years old can take part to help researchers understand normal bone health.
This study tests whether a natural gut hormone called GIP can reduce nausea by increasing blood flow to the gut. Researchers want to see how this works in healthy people.
Hear when a new Obesity and Obesity-related Medical Conditions trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.